NutraBrain: Home Ketamine Rx

08/10/2026

Who gets rejected from my services?

07/08/2026

07/08/2026

07/08/2026

Is your anti-depressant enough?

08/07/2025

1M Followers, 2,313 Following, 190 Posts

12/18/2024

Recent research has revealed that ketamine’s antidepressant effects may primarily involve astroglia—supporting cells in the brain—rather than neurons, as previously thought. In studies using zebrafish, scientists observed that ketamine reduced “giving up” behaviors by overstimulating astroglia, which decreased their sensitivity to stress signals and increased persistence. Whole-brain imaging showed prolonged activation of astrocytes following ketamine administration, indicating a significant role for these cells in the drug’s effects.

These findings were further supported by similar results in mice, suggesting that targeting astroglia could be a promising avenue for developing new depression treatments. This challenges the traditional focus on neurons in antidepressant research and opens the door to exploring astroglia as key players in mood regulation. The study underscores the potential of astroglia as therapeutic targets, which may lead to more effective and safer antidepressant options in the future.

If you have questions about Ketamine, including whether it might be right for you, call us for a complementary consultation:
424–278–4241

11/14/2024

University at Buffalo researchers have uncovered how low-dose ketamine quickly lifts depression by selectively affecting NMDA receptors in the brain. Unlike traditional antidepressants that take weeks, ketamine offers near-instant relief by targeting specific NMDA receptors, which boosts brain excitatory activity. This rapid effect initiates long-term neural changes, providing sustained mood improvement. This discovery may pave the way for new depression treatments using ketamine-like drugs that deliver rapid relief with fewer side effects.